Repaglinide and Lorazepam drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Repaglinide (repaglinide) and Lorazepam (lorazepam). Common drug interactions include dyspnoea among females and hypotension among males.
The phase IV clinical study analyzes what interactions people have when they take Repaglinide and Lorazepam. It is created by eHealthMe based on reports of 131 people who take the same drugs from the FDA, and is updated regularly.
What is Repaglinide?
Repaglinide has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 8,226 Repaglinide users. Check the latest studies of Repaglinide.
What is Lorazepam?
Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
131 people who take Repaglinide and Lorazepam together, and have interactions are studied.

What are the common drug interactions of Repaglinide and Lorazepam, by gender? *
What are the common drug interactions of Repaglinide and Lorazepam, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Repaglinide and Lorazepam?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Repaglinide (8,226 reports)
- Lorazepam (165,639 reports)
Browse all drug interactions of Repaglinide and Lorazepam:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Repaglinide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Lorazepam:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Repaglinide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lorazepam and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on repaglinide and lorazepam (the active ingredients of Repaglinide and Lorazepam, respectively), and Repaglinide and Lorazepam (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Rituxan and Xeljanz Xr - a second ago
- Respiratory Distress and drugs of ingredients of triamcinolone acetonide - 5 seconds ago
- Could Flomax cause Atrioventricular Block Complete? - 42 seconds ago
- Could Amoxicillin cause Eyes - Bulging? - 43 seconds ago
- Axillary Pain and drugs of ingredients of natalizumab - 45 seconds ago
- Pain and drugs of ingredients of gramicidin; neomycin sulfate; polymyxin b sulfate - 46 seconds ago
- Right Ventricular Failure and drugs of ingredients of metronidazole - 48 seconds ago
- Protein Urine Present and drugs of ingredients of nevirapine - 48 seconds ago
- Pneumonia Influenzal and drugs of ingredients of ibuprofen - 48 seconds ago
- Hypertensive Crisis and drugs of ingredients of rasagiline mesylate - 51 seconds ago